Type II kinase inhibitors that target Parkinson's disease-associated LRRK2.

Volume:Pages
11(23):eadt2050
Site
Pubmed id
40465731
Authors

Raig ND, Surridge KJ, Sanz-Murillo M, Dederer V, Krämer A, Schwalm MP, Lattal NM, Elson L, Chatterjee D, Mathea S, Hanke T, Leschziner AE, Reck-Peterson SL, Knapp S

DOI
10.1126/sciadv.adt2050
Journal
Sci Adv
Publication Date
2025-6-4
Year
2025
N Publication Date
PI authors
Validated
Y